This topic contains a solution. Click here to go to the answer

Author Question: A nurse is discussing motor symptoms with a patient with Parkinson's disease who has been taking ... (Read 81 times)

sheilaspns

  • Hero Member
  • *****
  • Posts: 567
A nurse is discussing motor symptoms with a patient with Parkinson's disease who has been taking levodopa/carbidopa (Sinemet) and who is now having regular tics. Which statement by the patient indicates understanding of this symptom?
 
  a. I may need to try a lower dose of Sinemet to reduce my tics.
  b. My provider may order clozapine to treat these tics.
  c. These tics are an indication that my dose of Sinemet is too low.
  d. This means I will have to have surgery to stop the symptoms.

Question 2

A nursing student wants to know why a patient who has been taking levodopa (Dopar) for years will now receive levodopa/carbidopa (Sinemet).
 
  The nurse explains the reasons that levodopa as a single agent is no longer available. Which statement by the student indicates a need for further education?
  a. Carbidopa increases the availability of levodopa in the central nervous system.
  b. Carbidopa reduces the incidence of nausea and vomiting.
  c. Combination products reduce peripheral cardiovascular side effects.
  d. Combination products cause fewer dyskinesias and decreased psychosis.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jliusyl

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

ANS: A
Levodopa can cause movement disorders. If they occur, a lower dose of levodopa may be required to alleviate them. Clozapine is an antipsychotic used to treat levodopa-induced psychoses. Movement disorders generally occur as the dose of levodopa increases. Surgery is a last option for treating movement disorders, after amantadine fails.

Answer to Question 2

ANS: D
Adding carbidopa to levodopa does not reduce the incidence of dyskinesias or psychosis. In fact, carbidopa can increase the intensity and the speed of onset of these effects. Carbidopa inhibits decarboxylation of levodopa in the intestine and peripheral tissues, leading to more levodopa in the CNS. Carbidopa cannot cross the blood-brain barrier, so it does not have this action in the CNS. Peripheral side effects are reduced, including nausea, vomiting, and cardiovascular effects.





 

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

For a complete list of videos, visit our video library